# Refractory massive chylothorax following robot-assisted laparoscopic splenectomy with pericardial devascularization treated with trans-jugular intrahepatic portosystemic shunt: a case report

**Authors:** Xiang Deng, Jun Xia

PMC · DOI: 10.3389/fmed.2024.1420157 · Frontiers in Medicine · 2024-09-04

## TL;DR

A rare case of massive chylothorax after robot-assisted laparoscopic splenectomy with pericardial devascularization is reported and treated with a trans-jugular intrahepatic portosystemic shunt.

## Contribution

This case report highlights the rare complication of chylothorax after robot-assisted LSPD and proposes TIPS as an effective treatment.

## Key findings

- Massive chylothorax can occur due to recurrence of portal hypertension after robot-assisted LSPD.
- Trans-jugular intrahepatic portosystemic shunt (TIPS) is an effective treatment for high-output chylothorax.
- Portal pressure monitoring and imaging are crucial to prevent thoracic duct fistulas.

## Abstract

The development of a chylothorax after robot-assisted laparoscopic splenectomy combined with pericardial devascularization (LSPD) is rare. The robot-assisted procedure is similar to the standard LSPD, but surgeons must remain vigilant about potential chylothorax caused by recurrence of portal hypertension in patients with cirrhosis, an event that leads to variceal bleeding in the gastric fundus or a massive chylothorax caused by a thoracic duct fistula. We report a rare case of massive chylothorax after robot-assisted LSPD and review the literature to help elucidate the mechanisms of portal hypertension after LSPD, reduce surgical complications, and improve long-term patient outcomes. After LSPD, portal pressure monitoring, coagulation function testing, and portal vein CT imaging help in excluding portal vein thromboses and ensuring appropriate anticoagulation to reduce the development of thoracic duct fistulas. If portal hypertension recurs after surgery and a high-output chylothorax develops, conservative treatment becomes ineffective. Treatment with an active trans-jugular intrahepatic portosystemic shunt (TIPS) is recommended to lower the portal pressure.

## Linked entities

- **Diseases:** cirrhosis (MONDO:0005155)

## Full-text entities

- **Diseases:** chylothorax (MESH:D002916), thoracic duct fistula (MESH:D005402), cirrhosis (MESH:D005355), portal hypertension (MESH:D006975), portal vein thromboses (MESH:D012170), variceal bleeding (MESH:D014648)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11408172/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11408172/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC11408172/full.md

---
Source: https://tomesphere.com/paper/PMC11408172